CFRD Management Through Technology - Amir Moheet, MBBS

Dr. Amir Moheet, Associate Professor in the Division of Endocrinology, Diabetes and Metabolism at University of Minnesota, gives an overview of the current option for insulin pumps, continuous glucose monitoring (CGM) and hybrid closed loop insulin. He reviews existing literature on the use of these technologies and their potential benefits in the management of CFRD. This presentation was part of CFRI's Virtual 34th National CF Education Conference on July 31, 2021.

CFRI's 34th National CF Education Conference was sponsored by Vertex Pharmaceuticals, Genentech, Gilead Sciences, Chiesi USA, AbbVie, and Ionis Pharmaceuticals.